Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Serostim Sales Plan Included Physician Kickbacks, Government Alleges

This article was originally published in The Pink Sheet Daily

Executive Summary

A former Serono regional sales manager is charged in Boston federal court with offering kickbacks for prescribing Serostim in 1999. The Boston U.S. Attorney alleges that a Serostim sales plan “required” regional directors to target high-prescribers of the AIDS wasting treatment with “financial incentives.”

You may also be interested in...



Serostim Investigation Leads To Indictment Of Four Former Serono Execs

Boston U.S. Attorney's office announces indictments by a federal grand jury against two former Serono VPs and two former regional sales directors. The indictment alleges the execs conspired to offer physicians all-expenses paid trips to a meeting in Cannes, France in exchange for writing Serostim prescriptions.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel